| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| REIMB | REIMB_KELA(202)_ICD10(M058) | Connective tissue diseases, rheumatoid arthritis and comparable disease, Other seropositive rheumatoid arthritis | 2878 | |
| REIMB | REIMB_KELA(202)_ICD10(M05) | Connective tissue diseases, rheumatoid arthritis and comparable disease, Seropositive rheumatoid arthritis | 2415 | |
| REIMB | REIMB_KELA(313)_ICD10(M058) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases), Other seropositive rheumatoid arthritis | 1696 | |
| REIMB | REIMB_KELA(281)_ICD10(M058) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab, Other seropositive rheumatoid arthritis | 1582 | |
| REIMB | REIMB_KELA(313)_ICD10(M05) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases), Seropositive rheumatoid arthritis | 1151 | |
| REIMB | REIMB_KELA(281)_ICD10(M05) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab, Seropositive rheumatoid arthritis | 988 | |
| REIMB | REIMB_KELA(202)_ICD10(M059) | Connective tissue diseases, rheumatoid arthritis and comparable disease, Seropositive rheumatoid arthritis, unspecified | 261 | |
| REIMB | REIMB_KELA(3006)_ICD10(M058) | Baricitinib, Other seropositive rheumatoid arthritis | 164 | |
| REIMB | REIMB_KELA(291)_ICD10(M058) | Tofacitinib, Other seropositive rheumatoid arthritis | 159 | |
| REIMB | REIMB_KELA(293)_ICD10(M058) | Baricitinib, Other seropositive rheumatoid arthritis | 150 | |
| REIMB | REIMB_KELA(3005)_ICD10(M058) | Tofacitinib, Other seropositive rheumatoid arthritis | 112 | |
| REIMB | REIMB_KELA(293)_ICD10(M05) | Baricitinib, Seropositive rheumatoid arthritis | 95 | |
| REIMB | REIMB_KELA(3006)_ICD10(M05) | Baricitinib, Seropositive rheumatoid arthritis | 92 | |
| REIMB | REIMB_KELA(291)_ICD10(M05) | Tofacitinib, Seropositive rheumatoid arthritis | 85 | |
| REIMB | REIMB_KELA(313)_ICD10(M059) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases), Seropositive rheumatoid arthritis, unspecified | 71 | |
| REIMB | REIMB_KELA(3005)_ICD10(M05) | Tofacitinib, Seropositive rheumatoid arthritis | 63 | |
| REIMB | REIMB_KELA(281)_ICD10(M059) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab, Seropositive rheumatoid arthritis, unspecified | 62 | |
| REIMB | REIMB_KELA(298)_ICD10(M058) | Name not found, Other seropositive rheumatoid arthritis | 57 | |
| REIMB | REIMB_KELA(3029)_ICD10(M058) | Upadacitinib, Other seropositive rheumatoid arthritis | 56 | |
| REIMB | REIMB_KELA(3029)_ICD10(M05) | Upadacitinib, Seropositive rheumatoid arthritis | 33 | |
| REIMB | REIMB_KELA(298)_ICD10(M05) | Name not found, Seropositive rheumatoid arthritis | 32 | |
| REIMB | REIMB_KELA(202)_ICD9(M05) | Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found | 11 | |
| REIMB | REIMB_KELA(3048)_ICD10(M058) | Name not found, Other seropositive rheumatoid arthritis | 9 | |
| REIMB | REIMB_KELA(313)_ICD10(M050) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases), Felty's syndrome | 8 | |
| REIMB | REIMB_KELA(202)_ICD10(M056) | Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found | 6 | |
| REIMB | REIMB_KELA(281)_ICD10(M050) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab, Felty's syndrome | 6 | |
| REIMB | REIMB_KELA(293)_ICD10(M059) | Baricitinib, Seropositive rheumatoid arthritis, unspecified | 5 | |
| REIMB | REIMB_KELA(3006)_ICD10(M059) | Baricitinib, Seropositive rheumatoid arthritis, unspecified | 5 |